Cargando…

Solvated interaction energy: from small-molecule to antibody drug design

Scoring functions are ubiquitous in structure-based drug design as an aid to predicting binding modes and estimating binding affinities. Ideally, a scoring function should be broadly applicable, obviating the need to recalibrate and refit its parameters for every new target and class of ligands. Tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Purisima, Enrico O., Corbeil, Christopher R., Gaudreault, Francis, Wei, Wanlei, Deprez, Christophe, Sulea, Traian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282643/
https://www.ncbi.nlm.nih.gov/pubmed/37351549
http://dx.doi.org/10.3389/fmolb.2023.1210576
_version_ 1785061171373539328
author Purisima, Enrico O.
Corbeil, Christopher R.
Gaudreault, Francis
Wei, Wanlei
Deprez, Christophe
Sulea, Traian
author_facet Purisima, Enrico O.
Corbeil, Christopher R.
Gaudreault, Francis
Wei, Wanlei
Deprez, Christophe
Sulea, Traian
author_sort Purisima, Enrico O.
collection PubMed
description Scoring functions are ubiquitous in structure-based drug design as an aid to predicting binding modes and estimating binding affinities. Ideally, a scoring function should be broadly applicable, obviating the need to recalibrate and refit its parameters for every new target and class of ligands. Traditionally, drugs have been small molecules, but in recent years biologics, particularly antibodies, have become an increasingly important if not dominant class of therapeutics. This makes the goal of having a transferable scoring function, i.e., one that spans the range of small-molecule to protein ligands, even more challenging. One such broadly applicable scoring function is the Solvated Interaction Energy (SIE), which has been developed and applied in our lab for the last 15 years, leading to several important applications. This physics-based method arose from efforts to understand the physics governing binding events, with particular care given to the role played by solvation. SIE has been used by us and many independent labs worldwide for virtual screening and discovery of novel small-molecule binders or optimization of known drugs. Moreover, without any retraining, it is found to be transferrable to predictions of antibody-antigen relative binding affinities and as accurate as functions trained on protein-protein binding affinities. SIE has been incorporated in conjunction with other scoring functions into ADAPT (Assisted Design of Antibody and Protein Therapeutics), our platform for affinity modulation of antibodies. Application of ADAPT resulted in the optimization of several antibodies with 10-to-100-fold improvements in binding affinity. Further applications included broadening the specificity of a single-domain antibody to be cross-reactive with virus variants of both SARS-CoV-1 and SARS-CoV-2, and the design of safer antibodies by engineering of a pH switch to make them more selective towards acidic tumors while sparing normal tissues at physiological pH.
format Online
Article
Text
id pubmed-10282643
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102826432023-06-22 Solvated interaction energy: from small-molecule to antibody drug design Purisima, Enrico O. Corbeil, Christopher R. Gaudreault, Francis Wei, Wanlei Deprez, Christophe Sulea, Traian Front Mol Biosci Molecular Biosciences Scoring functions are ubiquitous in structure-based drug design as an aid to predicting binding modes and estimating binding affinities. Ideally, a scoring function should be broadly applicable, obviating the need to recalibrate and refit its parameters for every new target and class of ligands. Traditionally, drugs have been small molecules, but in recent years biologics, particularly antibodies, have become an increasingly important if not dominant class of therapeutics. This makes the goal of having a transferable scoring function, i.e., one that spans the range of small-molecule to protein ligands, even more challenging. One such broadly applicable scoring function is the Solvated Interaction Energy (SIE), which has been developed and applied in our lab for the last 15 years, leading to several important applications. This physics-based method arose from efforts to understand the physics governing binding events, with particular care given to the role played by solvation. SIE has been used by us and many independent labs worldwide for virtual screening and discovery of novel small-molecule binders or optimization of known drugs. Moreover, without any retraining, it is found to be transferrable to predictions of antibody-antigen relative binding affinities and as accurate as functions trained on protein-protein binding affinities. SIE has been incorporated in conjunction with other scoring functions into ADAPT (Assisted Design of Antibody and Protein Therapeutics), our platform for affinity modulation of antibodies. Application of ADAPT resulted in the optimization of several antibodies with 10-to-100-fold improvements in binding affinity. Further applications included broadening the specificity of a single-domain antibody to be cross-reactive with virus variants of both SARS-CoV-1 and SARS-CoV-2, and the design of safer antibodies by engineering of a pH switch to make them more selective towards acidic tumors while sparing normal tissues at physiological pH. Frontiers Media S.A. 2023-06-07 /pmc/articles/PMC10282643/ /pubmed/37351549 http://dx.doi.org/10.3389/fmolb.2023.1210576 Text en Copyright © 2023 Purisima, Corbeil, Gaudreault, Wei, Deprez and Sulea. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Purisima, Enrico O.
Corbeil, Christopher R.
Gaudreault, Francis
Wei, Wanlei
Deprez, Christophe
Sulea, Traian
Solvated interaction energy: from small-molecule to antibody drug design
title Solvated interaction energy: from small-molecule to antibody drug design
title_full Solvated interaction energy: from small-molecule to antibody drug design
title_fullStr Solvated interaction energy: from small-molecule to antibody drug design
title_full_unstemmed Solvated interaction energy: from small-molecule to antibody drug design
title_short Solvated interaction energy: from small-molecule to antibody drug design
title_sort solvated interaction energy: from small-molecule to antibody drug design
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282643/
https://www.ncbi.nlm.nih.gov/pubmed/37351549
http://dx.doi.org/10.3389/fmolb.2023.1210576
work_keys_str_mv AT purisimaenricoo solvatedinteractionenergyfromsmallmoleculetoantibodydrugdesign
AT corbeilchristopherr solvatedinteractionenergyfromsmallmoleculetoantibodydrugdesign
AT gaudreaultfrancis solvatedinteractionenergyfromsmallmoleculetoantibodydrugdesign
AT weiwanlei solvatedinteractionenergyfromsmallmoleculetoantibodydrugdesign
AT deprezchristophe solvatedinteractionenergyfromsmallmoleculetoantibodydrugdesign
AT suleatraian solvatedinteractionenergyfromsmallmoleculetoantibodydrugdesign